SCHEMBL12445884

SCHEMBL12445884

CC1CC(S)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10314783 0.96
SCHEMBL11358986 0.84 CYP2C9 (0.30)
SCHEMBL18534228 0.82
SCHEMBL7044994 0.82
SCHEMBL18220758 0.77 L3MBTL1 (0.33)
SCHEMBL18526306 0.74
SCHEMBL9072966 0.74
SCHEMBL20428013 0.74 EPHX2 (0.30)
SCHEMBL23420992 0.71
SCHEMBL11810630 0.71 EPHX2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130011444-A1 COMPOSITIONS AND METHODS FOR OVERCOMING RESISTANCE TO TRAMADOL SYNTRIX BIOSYSTEMS, INC. (US) 2013-01-10 US disclosed
US-8003565-B2 Platinum-ruthenium containing catalyst formulations for hydrogen generation HONDA GIKEN KOGYO KABUSHIKI KAISHA (JP) 2011-08-23 US disclosed
US-20110008383-A1 COMPOSITIONS OF TOLL-LIKE RECEPTOR AGONISTS AND MALARIA ANTIGENS AND METHODS OF USE VAXINNATE CORPORATION 2011-01-13 US disclosed
EP-2170368-B1 LIQUID PROTEIN FORMULATIONS COMPRISING GDF-5 FOR USE AT ELEVATED TEMPERATURES ATRM LLC (US) 2011-01-05 EP disclosed
US-20100034809-A1 Compositions and Methods for Antibodies Targeting Complement Protein C5 NOVARTIS AG 2010-02-11 US disclosed
US-7650747-B2 Method and apparatus for exhaust gas purifying using hydrocarbon-selective catalytic reduction GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) 2010-01-26 US disclosed
EP-2113571-A1 Improved method for detection of ATP PROMEGA CORPORATION (US) 2009-11-04 EP disclosed
US-7431929-B2 Use of vaccinia virus deleted for the E3L gene as a vaccine vector ARIZONA BOARD OF REGENTS (US) 2008-10-07 US disclosed
US-20070165409-A1 Projection display and image display method PANASONIC CORPORATION (JP) 2007-07-19 US disclosed